List of Conzip drug patents
Conzip is owned by Cipher Pharms Inc.
Conzip contains Tramadol Hydrochloride.
Conzip has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Conzip are:
- US7858118
Conzip was authorised for market use on 07 May, 2010.
Conzip is available in capsule, extended release;oral dosage forms.
Conzip can be used as use of tramadol for the management of moderate to moderately severe chronic pain.
The generics of Conzip are possible to be released after 11 April, 2022.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7858118 | CIPHER PHARMS INC | Extended release composition containing Tramadol |
Apr, 2022
(1 year, 1 month ago) | |
Drugs and Companies using TRAMADOL HYDROCHLORIDE ingredient
Market Authorisation Date: 07 May, 2010
Treatment: Use of tramadol for the management of moderate to moderately severe chronic pain
Dosage: CAPSULE, EXTENDED RELEASE;ORAL
CONZIP family patents
6
United States
1
Canada
1
Australia
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic